Dynamics within the CD95 death-inducing signaling complex decide life and death of cells

被引:113
|
作者
Neumann, Leo [1 ,4 ]
Pforr, Carina [2 ]
Beaudouin, Joel [1 ,4 ]
Pappa, Alexander [2 ,3 ]
Fricker, Nicolai [2 ]
Krammer, Peter H. [2 ]
Lavrik, Inna N. [2 ]
Eils, Roland [1 ,4 ]
机构
[1] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Div Immunogenet, D-69120 Heidelberg, Germany
[3] Medac GmbH, Wedel Hamburg, Germany
[4] Univ Heidelberg, Inst Pharm & Mol Biotechnol, Dept Bioinformat & Funct Genom, Heidelberg, Germany
关键词
apoptosis; CD95; signaling; DISC; model reduction; NF-kappa B; NF-KAPPA-B; RECEPTOR-INDUCED APOPTOSIS; CASPASE-8; ACTIVATION; CD95-INDUCED APOPTOSIS; LONG FORM; T-CELLS; C-FLIPL; INHIBITOR; MODEL; FADD;
D O I
10.1038/msb.2010.6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study explores the dilemma in cellular signaling that triggering of CD95 (Fas/APO-1) in some situations results in cell death and in others leads to the activation of NF-kappa B. We established an integrated kinetic mathematical model for CD95-mediated apoptotic and NF-kappa B signaling. Systematic model reduction resulted in a surprisingly simple model well approximating experimentally observed dynamics. The model postulates a new link between c-FLIPL cleavage in the death-inducing signaling complex (DISC) and the NF-kappa B pathway. We validated experimentally that CD95 stimulation resulted in an interaction of p43-FLIP with the IKK complex followed by its activation. Furthermore, we showed that the apoptotic and NF-kappa B pathways diverge already at the DISC. Model and experimental analysis of DISC formation showed that a subtle balance of c-FLIPL and procaspase-8 determines life/death decisions in a nonlinear manner. We present an integrated model describing the complex dynamics of CD95-mediated apoptosis and NF-kappa B signaling. Molecular Systems Biology 6: published online 9 March 2010; doi: 10.1038/msb.2010.6
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Partial equilibrium approximations in apoptosis. II. The death-inducing signaling complex subsystem
    Huang, Ya-Jing
    Hong, Liu
    Yong, Wen-An
    MATHEMATICAL BIOSCIENCES, 2015, 270 : 126 - 134
  • [22] Inorganic mercury attenuates CD95-mediated apoptosis by interfering with formation of the death inducing signaling complex
    McCabe, MJ
    Whitekus, MJ
    Hyun, J
    Eckles, KG
    McCollum, G
    Rosenspire, AJ
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 190 (02) : 146 - 156
  • [23] Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase
    Choi, H.
    Chang, J-W
    Jung, Y-K
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (03) : 405 - 414
  • [24] Regulation of death receptor-induced apoptosis induced via CD95/Fas and other death receptors
    Lavrik, I. N.
    MOLECULAR BIOLOGY, 2011, 45 (01) : 150 - 155
  • [25] Regulation of hippocampal Fas receptor and death-inducing signaling complex after kainic acid treatment in mice
    Keller, Benjamin
    Garcia-Sevilla, Jesus A.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2015, 63 : 54 - 62
  • [26] NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II
    Pescatore, Alessandra
    Esposito, Elio
    Draber, Peter
    Walczak, Henning
    Ursini, Matilde Valeria
    CELL DEATH & DISEASE, 2016, 7 : e2346 - e2346
  • [27] cMet and fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cells
    Smyth, LA
    Brady, HJM
    HYPERTENSION, 2005, 46 (01) : 100 - 106
  • [28] Lens epithelial cells express CD95 and CD95 ligand treatment induces cell death and DNA fragmentation in vitro
    Hueber, A
    Eichholtz, CD
    Kociok, N
    Esser, JM
    Esser, PJ
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2003, 13 (03) : 241 - 245
  • [29] Solution NMR Investigation of the CD95/FADD Homotypic Death Domain Complex Suggests Lack of Engagement of the CD95 C Terminus
    Esposito, Diego
    Sankar, Andrew
    Morgner, Nina
    Robinson, Carol V.
    Rittinger, Katrin
    Driscoll, Paul C.
    STRUCTURE, 2010, 18 (10) : 1378 - 1390
  • [30] Therapeutic Targeting of CD95 and the TRAIL Death Receptors
    Gerspach, Jeannette
    Pfizenmaier, Klaus
    Wajant, Harald
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (03) : 294 - 310